Eligibility criteria are described in Table 1 . The ORGAVADS study focuses on patients with surgically resectable HNSCC who undergo surgery at François Baclesse Center and Caen University Hospital Center. After patient screening according to criteria, and the patient’s non-opposition, the patient will be enrolled in the study. An identification number will be thus assigned to each patient to be used throughout the study.
ORGAVADS study inclusion and exclusion criteria
| Inclusion criteria | Non-inclusion criteria |
|---|---|
| Patient ≥ 18 years | Pregnant women |
| Histologically confirmed squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx or larynx | Patient deprived of liberty or placed under the authority of a tutor |
| Patients for whom oncologic surgery is planned or who have recently undergone surgery of the tumor of oral cavity, oropharynx, hypopharynx or larynx | |
| Subject affiliated to a social security regimen | |
| No opposition to participate to the study |
Free full text: Click here
